sodium arsenite has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, I; Kim, S; Koh, Y; Liu, Y; Oh, S; Shin, DY | 1 |
| Centeno, F; Coleman, MA; Córdova, EJ; Koneru, H; Martínez-Hernández, A; Morales-Marín, M; Orozco, L; Uribe-Figueroa, L | 1 |
2 other study(ies) available for sodium arsenite and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenites; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Ergocalciferols; G2 Phase Cell Cycle Checkpoints; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sodium Compounds | 2017 |
The NRF2-KEAP1 pathway is an early responsive gene network in arsenic exposed lymphoblastoid cells.
Topics: Apoptosis; Arsenites; Cell Line, Tumor; Gene Expression; Gene Regulatory Networks; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Sodium Compounds | 2014 |